Eisai to reap wider benefits from new Fiocruz alliance?
This article was originally published in Scrip
Executive Summary
Eisai is strengthening its growing credentials as an active player in the neglected diseases space through an alliance with Brazil's Fundação Oswaldo Cruz (Fiocruz) for the development of new drugs and vaccines for malaria and other neglected tropical diseases.